04:11 PM EST, 01/15/2025 (MT Newswires) -- Timothy A Springer, 10% Owner, Director, on January 13, 2025, executed a purchase for 20,967 shares in Cartesian Therapeutics ( RNAC ) for $366,354. Following the Form 4 filing with the SEC, Springer has control over a total of 9,391,955 shares of the company, with 8,531,462 shares held directly and 860,493 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1453687/000145368725000047/xslF345X05/wk-form4_1736975300.xml